GL1X · GenesisL1 explorer

Research workbench

Human JAK1 kinase domain in complex with inhibitor

Analyse Human JAK1 kinase domain in complex with inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6SM8
Type
protein
Length
581 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase JAK1
EC
2.7.10.2
UniProt
P23458
Ligands
LKT
Pockets
9 · best druggability 0.67

Structure

x-ray diffraction · 2 distinct chains · 42% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase JAK1 (EC 2.7.10.2)protein29741% helix, 20% strandP23458
BTyrosine-protein kinase JAK1 (EC 2.7.10.2)protein28443% helix, 21% strandP23458

Ligands and binding sites

  • LKT · 2-chloranyl-6-[(3~{S})-3-[(1~{S})-2-cyano-1-[4-(7~{H}-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]ethyl]pyrrolidin-1-yl]benzenecarbonitrile · ligand · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 2 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12360.670.8432LKT
22460.650.8337LKT
31340.560.8327empty
41180.550.8327empty
51060.380.7528empty

Interfaces

1 interface between chains.

  • A–B · 929 Ų buried · 16 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified (phosphorylation).

Compared structures

  • 6SM8 · Human jak1 kinase domain in complex with inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.